Covered recipient · General Payments record
BRANDON J GEER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,774.91
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.06 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $107.21 | 5 |
| ABIOMED | $92.14 | 1 |
| Neurelis, Inc. | $74.81 | 1 |
| Acerta Pharma LLC | $46.99 | 2 |
| PFIZER INC. | $36.37 | 1 |
| Merck Sharp & Dohme Corporation | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $92.14 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142271637 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104729235 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.54 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105716964 | CMS |
| Merck Sharp & Dohme LLC | $17.54 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141594442 | CMS |
| Neurelis, Inc. | $74.81 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145663874 | CMS |
| Novo Nordisk Inc | $21.83 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100359646 | CMS |
| Novo Nordisk Inc | $21.12 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100551504 | CMS |
| Novo Nordisk Inc | $17.22 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100439137 | CMS |
| Novo Nordisk Inc | $20.69 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100445753 | CMS |
| Novo Nordisk Inc | $26.35 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100626810 | CMS |
| PFIZER INC. | $36.37 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131578787 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.